VF
XFOR icon

Virtu Financial’s X4 Pharmaceuticals XFOR Stock Holding History

Virtu Financial’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,730
Closed -$53K – 2333
2026
Q1 		$53K Sell
12,730
-9,759
-43% -$36.6K ﹤0.01% 1281
2025
Q4 		$90K Buy
+22,489
New +$81.7K ﹤0.01% 1224
2025
Q3 		– Sell
-12,587
Closed -$24K – 2167
2025
Q2 		$24K Buy
12,587
+10,343
+461% +$42.3K ﹤0.01% 1239
2025
Q1 		$16K Buy
+2,244
New +$30.9K ﹤0.01% 1139
2024
Q3 		– Sell
-1,685
Closed -$29K – 1951
2024
Q2 		$29K Buy
+1,685
New +$55.1K ﹤0.01% 987
2024
Q1 		– Sell
-4,257
Closed -$107K – 2184
2023
Q4 		$107K Buy
+4,257
New +$104K 0.01% 1018
2023
Q3 		– Sell
-503
Closed -$29K – 1985
2023
Q2 		$29K Sell
503
-3,280
-87% -$169K ﹤0.01% 1212
2023
Q1 		$99K Buy
+3,783
New +$111K 0.01% 986
2022
Q3 		– Sell
-680
Closed -$20K – 2297
2022
Q2 		$20K Sell
680
-186
-21% -$7.08K ﹤0.01% 1332
2022
Q1 		$45K Buy
+866
New +$49.7K ﹤0.01% 1165
2019
Q1 		– Sell
-196
Closed -$82K – 1909
2018
Q4 		$82K Buy
196
+69
+54% +$26.3K ﹤0.01% 1180
2018
Q3 		$37K Buy
+127
New +$53.9K ﹤0.01% 1346

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtu Financial's XFOR Position: Q2 2026 in Review

Virtu Financial sold out of X4 Pharmaceuticals (XFOR) in Q2 2026, closing a stake of 12,730 shares — an estimated $53K sold.

Virtu Financial first reported a position in XFOR in Q3 2018 and held it in 12 quarters. The position peaked at $107K in Q4 2023. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Virtu Financial reported no remaining X4 Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 12,730 X4 Pharmaceuticals shares in Q2 2026, an estimated $53K.
  • Virtu Financial first reported a position in X4 Pharmaceuticals in Q3 2018 and held it in 12 quarters.
  • Virtu Financial's X4 Pharmaceuticals position peaked at $107K in Q4 2023.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.